| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/21/2009 | US7521064 Insertion into vagina; prevention, therapy for infections |
| 04/21/2009 | US7521061 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/21/2009 | CA2434964C Carrier with solid fibrinogen and solid thrombin |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2380068C Pullulan film compositions |
| 04/21/2009 | CA2356743C Percutaneously absorptive preparation |
| 04/21/2009 | CA2338358C Compounds and compositions for delivering active agents |
| 04/21/2009 | CA2320878C Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/21/2009 | CA2309038C Use of inhaled no as anti-inflammatory agent |
| 04/21/2009 | CA2299420C Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 04/21/2009 | CA2279184C Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine |
| 04/21/2009 | CA2221341C Submicron liposome suspensions obtained from preliposome lyophilizates |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/19/2009 | CA2641248A1 Patch preparation |
| 04/16/2009 | WO2009049242A1 Autophagy inducing compounds and uses thereof in treating autophagy associated diseases |
| 04/16/2009 | WO2009049190A1 Improved topical pain relief product |
| 04/16/2009 | WO2009049008A2 Porous pressure sensitive adhesive and tapes |
| 04/16/2009 | WO2009048959A1 Rapid acting injectable insulin compositions |
| 04/16/2009 | WO2009048958A2 Methods and compositions involving chitosan nanoparticles |
| 04/16/2009 | WO2009048945A1 Rapid mucosal gel or film insulin compositions |
| 04/16/2009 | WO2009048924A1 Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents |
| 04/16/2009 | WO2009048848A1 Pharmaceutical formulation of valsartan |
| 04/16/2009 | WO2009048841A1 Antifungal treatment of nails |
| 04/16/2009 | WO2009048698A1 Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents |
| 04/16/2009 | WO2009048606A1 Extrudable and extruded compositions for delivery of bioactive agents, method of making the same and method of using same |
| 04/16/2009 | WO2009048594A2 Multicomponent bioactive intravaginal ring |
| 04/16/2009 | WO2009048557A1 Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| 04/16/2009 | WO2009048352A1 Water-dispersible organic medicinal substance in the form of a micronised powder of n-carbamoil-methyl-4-phenyl-2-pyrrolidone and a method for micronising it |
| 04/16/2009 | WO2009048314A1 A scalable matrix for the in vivo cultivation of bone and cartilage |
| 04/16/2009 | WO2009048280A2 Long acting hyaluronic acid - peptide conjugate |
| 04/16/2009 | WO2009048166A1 Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy |
| 04/16/2009 | WO2009048120A1 Water-soluble composition containing astaxanthin |
| 04/16/2009 | WO2009048073A1 Method of coating granules |
| 04/16/2009 | WO2009047935A1 Fine particles |
| 04/16/2009 | WO2009047859A1 Granular jelly beverage for medication and process for producing the same |
| 04/16/2009 | WO2009047826A2 Pharmaceutical composition comprising sucralphate and mesalazine |
| 04/16/2009 | WO2009047802A2 Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof |
| 04/16/2009 | WO2009047801A1 Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
| 04/16/2009 | WO2009047800A2 Oral controlled release composition of carvedilol |
| 04/16/2009 | WO2009047788A2 Topical composition containing the combination of mupirocin and beclomethasone |
| 04/16/2009 | WO2009047785A2 A non-aqueous topical solution of diclofenac and process for preparing the same |
| 04/16/2009 | WO2009047640A2 Method for treating and/or preventing photoreceptor damage in retina |
| 04/16/2009 | WO2009047634A2 Aqueous formulations of acetaminophen for injection |
| 04/16/2009 | WO2009047633A2 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate |
| 04/16/2009 | WO2009047434A2 Use of carriers as preservatives and pharmaceutical composition containing same |
| 04/16/2009 | WO2009047321A2 A sublingual effervescent tablet of progesterone associated with cyclodextrin |
| 04/16/2009 | WO2009047312A1 Solid pharmaceutical composition comprising tamsulosin |
| 04/16/2009 | WO2009047300A2 Device for administering cells and cell-therapy methods using said device |
| 04/16/2009 | WO2009047006A2 Amphoteric liposomes comprising neutral lipids |
| 04/16/2009 | WO2009046930A1 Microcapsules based on waxes |
| 04/16/2009 | WO2009046632A1 Pharmaceutical composition containing angiotensin ii receptor blocker and b family vitamins and use thereof |
| 04/16/2009 | WO2009046631A1 Pharmaceutical composition containing angiotensin converting enzyme inhibitor and b family vitamins and use thereof |
| 04/16/2009 | WO2009046620A1 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 04/16/2009 | WO2009046573A1 Liver targeting adefovir prodrug and its medical use |
| 04/16/2009 | WO2009046530A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | WO2009026306A3 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 04/16/2009 | WO2009021127A3 Controlled released compositions |
| 04/16/2009 | WO2009020607A3 Method and apparatus for composite drug delivery medical devices |
| 04/16/2009 | WO2009019371A3 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 04/16/2009 | WO2009015279A3 Agents and methods for inhibition of airway hyperresponsiveness |
| 04/16/2009 | WO2009007992A3 Pharmaceutical composition produced by microprecipitation |
| 04/16/2009 | WO2008149096A3 Polymeric microparticles |
| 04/16/2009 | WO2008143812A4 Biologic devices for hemostasis |
| 04/16/2009 | WO2008139210A3 Process for obtaining steroidal phosphate compounds |
| 04/16/2009 | WO2008116004A3 Transdermal patch and method for delivery of vitamin b12 |
| 04/16/2009 | WO2008106503A8 Discrete size and shape specific pharmaceutical organic nanoparticles |
| 04/16/2009 | WO2008095195A3 Lyophilized formulations of salinosporamide a |
| 04/16/2009 | WO2008070072A3 Carvedilol forms, compositions, and methods of preparation thereof |
| 04/16/2009 | WO2008066899A3 Nanoparticulate formulations and methods for the making and use thereof |
| 04/16/2009 | WO2008062449A3 A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol |
| 04/16/2009 | WO2008062417A3 Protecting algae from body fluids |
| 04/16/2009 | WO2008041846A3 Hydroxyapatite tissue filler and its preparation and use |
| 04/16/2009 | WO2008029417A3 Pharmaceutical formulation for use in hiv therapy |
| 04/16/2009 | WO2008027218A3 Drug electrotransport with hydration measurement of hydratable reservoir |
| 04/16/2009 | WO2008025425A8 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same |
| 04/16/2009 | WO2008017867A3 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 04/16/2009 | WO2007129178A3 Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic- analgesic drug and proton pump inhibitor |
| 04/16/2009 | WO2007129176A3 Improvements in therapy for treating resistant bacterial infections |
| 04/16/2009 | WO2007122474A3 Extended release formulations |
| 04/16/2009 | WO2007110753A3 Extended release dosage forms of metoprolol |
| 04/16/2009 | WO2007086923A3 Controlled and sustained gene transfer mediated by thiol-modified polymers |
| 04/16/2009 | WO2007069061A3 Controlled release compositions containing zolpidem |
| 04/16/2009 | WO2007063424A3 The modulation of immunity and ceacam1 activity |
| 04/16/2009 | WO2007044748A3 Sphingomyelin liposomes for the treatment of hyperactive bladder disorders |
| 04/16/2009 | WO2007038274A3 Effervescent oral care compositions and methods of use |
| 04/16/2009 | WO2007034287A3 Oramucosal pharmaceutical dosage form |
| 04/16/2009 | WO2007031887A3 Extended release pharmaceutical composition of metformin and a process for producing it |
| 04/16/2009 | WO2007014061A3 Coated tables with zero-order or near zero-order release kinetics |
| 04/16/2009 | WO2007008576A3 Oxcarbazepine formulation |
| 04/16/2009 | WO2007002362A3 A direct drug delivery system based on thermally responsive biopolymers |
| 04/16/2009 | WO2006133271A3 Compositions and methods relating to target-specific photodynamic therapy |
| 04/16/2009 | WO2006130703A3 Modified release formulations of anti-irritability drugs |
| 04/16/2009 | WO2006110889A3 Multi-layer structure having a predetermined layer pattern including an agent |
| 04/16/2009 | WO2006096205A3 Carbon and metal nanomaterial composition and synthesis |
| 04/16/2009 | WO2006076416A3 Three dimensional cell protector/pore architecture formation for bone and tissue constructs |
| 04/16/2009 | WO2006055008A3 Implantable sensors and implantable pumps and anti-scarring agents |
| 04/16/2009 | WO2006015260A3 Method for measuring the incidence of hospital acquired infections |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2006007514A3 Methods for producing functional antigen presenting dentritic cells using biodegradable microparticles for delivery of antigenic materials |